Clients

	BloXR President -Ashok Khandkar, PhD BloXR Corporation has developed and intends to commercialize novel, industry first, easy to use products for protection against the harmful effects of ionizing radiation.
	ZIEN Medical CEO – Tim Nieman ZIEN Medical is committed to helping medical device companies realize products. ZIEN provides the product development, resourcing, quality systems, and regulatory expertise to facilitate rapid product development. They also provide the contract manufacturing and commercialization activities that small businesses need to compete in a regulated environment.
	Symbion Discovery President/CEO – Duane Rufner, Ph.D. VP of Business Development – Sheryl Hohle Symbion Discovery is a small molecule drug discovery company founded in January 2009. The company’s primary interest is in discovering and developing natural compounds that have selective toxicity, including: antivirals for use against Human Immunodeficiency Virus (HIV); and anti-cancer drugs for use against metastatic tumors.
	Knudra CEO – Chris Hopkins, Ph.D. Knudra is using novel technology to develop assay kits that detect toxicity more accurately and efficiently than current methods by using transgenic nematodes to rapidly screen compounds for their specific cellular toxicity.